MycoTechnology

MycoTechnology

Private
Aurora, ColoradoHealthcare & Life Scienceshttps://www.mycoiq.com

Last Round

Series E

Mar 30, 2022

Total Funding Raised

$207.6M

Company Overview

MycoTechnology is a food technology company that enhances the nutritional qualities of food products through a unique processing platform utilizing gourmet fungi and mycelial fermentation.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials, Advanced Materials

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

food ingredientsmushroom fermentationmycelium technologyflavor modulatorplant-based proteinfood techalternative proteinfermentation technologyprecision fermentationbiomass fermentationoff-note maskingsweetness modulatormycoproteinFermentation as a ServiceFaaSfood formulationagrifood tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MycoTechnology Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

MycoTechnology Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series EMar 30, 2022
GrantNov 3, 2020
Series DJun 11, 2020
Series CJan 30, 2019
Series BOct 20, 2017
Series A
Oct 16, 2015

Key People

Founding team and executive leadership

Jordi Ferre

Chief Executive Officer

Executive Team

Ranjan Patnaik

Chief Technology Officer

Executive Team

Jerry Dreiling

Chief Financial Officer

Executive Team

Rick Becker

Chief Operating Officer

Executive Team

MycoTechnology Investors

Notable investors and investment history

InvestorRounds
GreatPoint VenturesSeries B
Bunge VenturesSeries E, Series D, Series B
Health for Life CapitalSeries C, Series B
Eighteen94 CapitalSeries C, Series D, Series B
GaingelsSeries E
Cerity Partners VenturesSeries B
Oman Investment AuthoritySeries E

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 12, 2026

    Honey Truffle Sweet Protein is now commercially available at scale in the U.S.

  • Aug 27, 2025

    Launched ClearHT, a natural flavor for sugar reduction.

MycoTechnology Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MycoTechnology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MycoTechnology's valuation, stock price, and market status.

Firmographic Details

HeadquartersAurora, Colorado
Employee Range84
Year Founded2013
Last FundingMar 30, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.